BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33382447)

  • 21. Effect of high cut-off dialysis for acute kidney injury secondary to cast nephropathy in patients with multiple myeloma: a systematic review and meta-analysis.
    Tarragón B; Ye N; Gallagher M; Sen S; Portolés JM; Wang AY
    Clin Kidney J; 2021 Aug; 14(8):1894-1900. PubMed ID: 34345412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
    Borrego-Hinojosa J; Pérez-del Barrio MP; Biechy-Baldan Mdel M; Merino-García E; Sánchez-Perales MC; García-Cortés MJ; Ocaña-Pérez E; Gutiérrez-Rivas P; Liébana-Cañada A
    Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy.
    Kleeberg L; Morgera S; Jakob C; Hocher B; Schneider M; Peters H; Rötzer S; Müller C; Kaiser M; Fleissner C; Heider U; Neumayer HH; Sezer O
    Eur J Med Res; 2009; 14(2):47-54. PubMed ID: 19258212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodialysis Using High Cut Off Filters in Light Chain Cast Nephropathy.
    Buus NH; Rantanen JM; Krag SP; Andersen NF; Jensen JD
    Blood Purif; 2015; 40(3):223-31. PubMed ID: 26376291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
    Finkel KW; Cohen EP; Shirali A; Abudayyeh A;
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2273-2279. PubMed ID: 27526708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience of using hemodialysis with medium cut-off dialyzer in cast nephropathy.
    Cazorla López JM; García García-Doncel A; Naranjo Muñoz J; Villanego Fernández F; Vigara Sánchez LA; Ceballos Guerrero M
    Nefrologia (Engl Ed); 2020; 40(3):367-369. PubMed ID: 32007298
    [No Abstract]   [Full Text] [Related]  

  • 27. Management options for cast nephropathy in multiple myeloma.
    Cockwell P; Hutchison CA
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):550-5. PubMed ID: 20827195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Light Chains Removal and Albumin Levels with a Double Filter-Based Extracorporeal Treatment for Acute Myeloma Kidney.
    Donati G; Zappulo F; Maietti E; Scrivo A; Gasperoni L; Zamagni E; Tacchetti P; Pantani L; Baraldi O; Comai G; Cappuccilli M; Cavo M; La Manna G
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal failure in multiple myeloma and its treatment.
    Ryšavá R
    Vnitr Lek; 2020; 66(7):425-431. PubMed ID: 33380121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clearance of drugs for multiple myeloma therapy during in vitro high-cutoff hemodialysis.
    Krieter DH; Devine E; Wanner C; Storr M; Krause B; Lemke HD
    Artif Organs; 2014 Oct; 38(10):888-93. PubMed ID: 24392952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.
    Yadav P; Hutchison CA; Basnayake K; Stringer S; Jesky M; Fifer L; Snell K; Pinney J; Drayson MT; Cook M; Cockwell P
    Eur J Haematol; 2016 Jun; 96(6):610-7. PubMed ID: 26248588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.
    Dimopoulos MA; Roussou M; Gavriatopoulou M; Psimenou E; Eleutherakis-Papaiakovou E; Migkou M; Matsouka C; Mparmparousi D; Gika D; Kafantari E; Ziogas D; Fotiou D; Panagiotidis I; Terpos E; Kastritis E
    Am J Hematol; 2016 May; 91(5):499-502. PubMed ID: 26890495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Free light chains reduction on acute kidney injury in multiple myeloma: critical role of high cut-off membranes].
    Buti E; Dervishi E; Ghiandai G; Mjeshtri A; Paudice N; Terreni A; Caldini A; Nozzoli C; Minetti EE; Bergesio F
    G Ital Nefrol; 2014; 31(6):. PubMed ID: 25504169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report.
    Donati G; Zappulo F; Croci Chiocchini AL; Comai G; Zamagni E; La Manna G
    Hemodial Int; 2019 Jul; 23(3):E97-E99. PubMed ID: 30791209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
    Cockwell P; Cook M
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):324-32. PubMed ID: 22920643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment.
    Sharma R; Jain A; Jandial A; Lad D; Khadwal A; Prakash G; Nada R; Aggarwal R; Ramachandran R; Varma N; Malhotra P
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):626-634. PubMed ID: 35610119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced elimination of cyclophosphamide by high cut-off haemodialysis: single-dose pharmacokinetics in a patient with cast nephropathy.
    Eden G; Kühn-Velten WN; Hafer C; Kielstein JT
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29301798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of High-Cut-Off Dialysis on Renal Recovery in Dialysis-Dependent Multiple Myeloma Patients: Results from a Case-Control Study.
    Gerth HU; Pohlen M; Görlich D; Thölking G; Kropff M; Berdel WE; Pavenstädt H; Brand M; Kümpers P
    PLoS One; 2016; 11(5):e0154993. PubMed ID: 27152520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.
    Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F
    Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expert consensus for the diagnosis and treatment of patients with renal impairment of multiple myeloma].
    Renal Impairment of Multiple Myeloma Collaborative Study Group
    Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):871-875. PubMed ID: 29136724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.